Pramod R. Saxena

10.3k total citations · 1 hit paper
220 papers, 8.3k citations indexed

About

Pramod R. Saxena is a scholar working on Physiology, Cardiology and Cardiovascular Medicine and Psychiatry and Mental health. According to data from OpenAlex, Pramod R. Saxena has authored 220 papers receiving a total of 8.3k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Physiology, 66 papers in Cardiology and Cardiovascular Medicine and 65 papers in Psychiatry and Mental health. Recurrent topics in Pramod R. Saxena's work include Migraine and Headache Studies (63 papers), Nitric Oxide and Endothelin Effects (53 papers) and Receptor Mechanisms and Signaling (38 papers). Pramod R. Saxena is often cited by papers focused on Migraine and Headache Studies (63 papers), Nitric Oxide and Endothelin Effects (53 papers) and Receptor Mechanisms and Signaling (38 papers). Pramod R. Saxena collaborates with scholars based in Netherlands, Mexico and United States. Pramod R. Saxena's co-authors include Michel D. Ferrari, A.H. Jan Danser, Carlos M. Villalón, Willem A. Bax, Antoinette MaassenVanDenBrink, Peter de Vries, Maarten A.D.H. Schalekamp, Pieter D. Verdouw, Peer Tfelt‐Hansen and Jan P.C. Heiligers and has published in prestigious journals such as Circulation, Neurology and The Journal of Physiology.

In The Last Decade

Pramod R. Saxena

219 papers receiving 7.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Angiotensin-Converting Enzyme in the Human Heart

1995 627 citations A.H. Jan Danser, Maarten A.D.H. Schalekamp et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pramod R. Saxena Netherlands	48	2.7k	2.6k	2.6k	2.3k	1.6k	220	8.3k
Édith Hamel Canada	59	1.6k 0.6×	797 0.3×	3.2k 1.2×	3.5k 1.5×	4.3k 2.7×	183	11.2k
Noboru Toda Japan	47	558 0.2×	1.8k 0.7×	3.6k 1.4×	1.6k 0.7×	1.4k 0.9×	211	7.2k
Diana N. Krause United States	47	914 0.3×	650 0.2×	1.7k 0.6×	1.3k 0.6×	960 0.6×	100	6.4k
Masaki Nakane United States	46	404 0.2×	1.8k 0.7×	5.7k 2.2×	3.0k 1.3×	2.0k 1.3×	144	10.7k
Antoinette MaassenVanDenBrink Netherlands	45	4.9k 1.8×	838 0.3×	1.8k 0.7×	730 0.3×	827 0.5×	222	6.9k
Carlos M. Villalón Mexico	40	2.4k 0.9×	544 0.2×	1.5k 0.6×	1.1k 0.5×	1.4k 0.9×	183	4.9k
David W. Busija United States	55	385 0.1×	1.0k 0.4×	2.8k 1.1×	2.8k 1.2×	1.9k 1.2×	264	9.0k
W. Feniuk United Kingdom	40	2.0k 0.7×	397 0.2×	1.9k 0.7×	2.4k 1.0×	2.3k 1.5×	100	6.0k
Eric T. MacKenzie France	61	811 0.3×	750 0.3×	2.1k 0.8×	3.5k 1.5×	3.4k 2.2×	202	12.2k
Merja Haaparanta‐Solin Finland	53	900 0.3×	1.0k 0.4×	1.6k 0.6×	1.4k 0.6×	1.7k 1.1×	191	8.0k

Countries citing papers authored by Pramod R. Saxena

Since Specialization

Citations

This map shows the geographic impact of Pramod R. Saxena's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pramod R. Saxena with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pramod R. Saxena more than expected).

Fields of papers citing papers by Pramod R. Saxena

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pramod R. Saxena. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pramod R. Saxena. The network helps show where Pramod R. Saxena may publish in the future.

Co-authorship network of co-authors of Pramod R. Saxena

This figure shows the co-authorship network connecting the top 25 collaborators of Pramod R. Saxena. A scholar is included among the top collaborators of Pramod R. Saxena based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pramod R. Saxena. Pramod R. Saxena is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kranenburg, Andor R., Anna Willems‐Widyastuti, Wolter J. Mooi, et al.. (2005). Chronic obstructive pulmonary disease is associated with enhanced bronchial expression of FGF‐1, FGF‐2, and FGFR‐1. The Journal of Pathology. 206(1). 28–38. 63 indexed citations

MaassenVanDenBrink, Antoinette & Pramod R. Saxena. (2004). Coronary Vasoconstrictor Potential of Triptans: A Review of In Vitro Pharmacologic Data. Headache The Journal of Head and Face Pain. 44(s1). S13–9. 36 indexed citations

Kapoor, Kapil, Udayasankar Arulmani, Jan P.C. Heiligers, et al.. (2003). Effects of BIBN4096BS on cardiac output distribution and on CGRP-induced carotid haemodynamic responses in the pig. European Journal of Pharmacology. 475(1-3). 69–77. 42 indexed citations

Schuijt, Martin P., René de Vries, Pramod R. Saxena, Maarten A.D.H. Schalekamp, & A.H. Jan Danser. (2002). Vasoconstriction is determined by interstitial rather than circulating angiotensin II. British Journal of Pharmacology. 135(1). 275–283. 34 indexed citations

Bhalla, Pankaj, Hari Shanker Sharma, Xiaoqian Ma, et al.. (2001). Molecular cloning, pharmacological properties and tissue distribution of the porcine 5‐HT_1B receptor. British Journal of Pharmacology. 133(6). 891–901. 19 indexed citations

Lannoy, Larissa M. de, et al.. (2001). Angiotensin converting enzyme is the main contributor to angiotensin I–II conversion in the interstitium of the isolated perfused rat heart. Journal of Hypertension. 19(5). 959–965. 24 indexed citations

Tom, Beril, René de Vries, Pramod R. Saxena, & A.H.J. Danser. (2001). Negative inotropic effect of bradykinin in porcine isolated atrial trabeculae: role of nitric oxide. Journal of Hypertension. 19(7). 1289–1293. 10 indexed citations

Schuijt, Martin P., et al.. (2000). At2 Receptor-Mediated Vasodilation in the Heart: Effect of Myocardial Infarction.. Hypertension. 36. 704–704. 4 indexed citations

Villalón, Carlos M., et al.. (1999). Canine external carotid vasoconstriction to methysergide, ergotamine and dihydroergotamine: role of 5‐HT_1B/1D receptors and α₂‐adrenoceptors. British Journal of Pharmacology. 126(3). 585–594. 58 indexed citations

10.

Saxena, Pramod R., Peter de Vries, Jan P.C. Heiligers, et al.. (1998). BMS-181885, a 5-HT1B/1D receptor ligand, in experimental models predictive of antimigraine activity and coronary side-effect potential. European Journal of Pharmacology. 351(3). 329–339. 9 indexed citations

11.

Stam, Wiro B., et al.. (1998). Functional characterisation of the pharmacological profile of the putative α1B-adrenoceptor antagonist, (+)-cyclazosin. European Journal of Pharmacology. 361(1). 79–83. 20 indexed citations

12.

Vergouwe, Monique N., Roel A. Ophoff, Susan L. Naylor, et al.. (1998). Chromosomal localization of the 5-HT1F receptor gene: no evidence for involvement in response to sumatriptan in migraine patients.. PubMed. 77(5). 415–20. 19 indexed citations

13.

Saxena, Pramod R. & Michel D. Ferrari. (1996). Monthly Update: Central & Peripheral Nervous Systems: Pharmacology of antimigraine 5-HT _1D receptor agonists. Expert Opinion on Investigational Drugs. 5(5). 581–593. 15 indexed citations

14.

Vries, Peter de, Jan P.C. Heiligers, Carlos M. Villalón, & Pramod R. Saxena. (1996). Blockade of porcine carotid vascular responses to sumatriptan by GR127935, a selective 5‐HT_1D receptor antagonist. British Journal of Pharmacology. 118(1). 85–92. 49 indexed citations

15.

Schoemaker, Regien G., et al.. (1995). Characterization of the positive and negative inotropic effects of acetylcholine in the human myocardium. European Journal of Pharmacology. 284(1-2). 119–127. 36 indexed citations

16.

Bax, Willem A., et al.. (1995). [Arg8]Vasopressin-induced responses of the human isolated coronary artery: effects of non-peptide receptor antagonists. European Journal of Pharmacology. 285(2). 199–202. 23 indexed citations

17.

Ferrari, Michel D. & Pramod R. Saxena. (1992). Clinical effects and mechanism of action of sumatriptan in migraine. Clinical Neurology and Neurosurgery. 94. 73–77. 31 indexed citations

18.

Saxena, Pramod R.. (1990). Cardiovascular pharmacology of 5-hydroxytryptamine : prospective therapeutic applications. Kluwer Academic Publishers eBooks. 48 indexed citations

19.

Saxena, Pramod R.. (1988). Further characterization of 5‐hydroxytryptamine₁‐like receptors mediating tachycardia in the cat: No apparent relationship to known subtypes of the 5‐hydroxytryptamine₁ binding site. Drug Development Research. 13(4). 245–258. 10 indexed citations

20.

Saxena, Pramod R.. (1972). THE EFFECTS OF ANTIMIGRAINE DRUGS ON THE VASCULAR RESPONSES BY-5-HYDROXYTRYPTAMINE AND RELATED BIOGENIC SUBSTANCES ON THE EXTERNAL CAROTID BED OF DOGS: POSSIBLE PHARMACOLOGICAL IMPLICATIONS TO THEIR ANTIMIGRAINE ACTION. Headache The Journal of Head and Face Pain. 12(2). 44–54. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact